Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Efficacy of PRIME, a Mobile App Intervention Designed to Improve Motivation in Young People With Schizophrenia.

Schlosser DA, Campellone TR, Truong B, Etter K, Vergani S, Komaiko K, Vinogradov S.

Schizophr Bull. 2018 Aug 20;44(5):1010-1020. doi: 10.1093/schbul/sby078.

PMID:
29939367
2.

Social motivation in people with recent-onset schizophrenia spectrum disorders.

Campellone TR, Truong B, Gard D, Schlosser DA.

J Psychiatr Res. 2018 Apr;99:96-103. doi: 10.1016/j.jpsychires.2018.01.006. Epub 2018 Jan 12.

3.

Potential Benefits of Incorporating Peer-to-Peer Interactions Into Digital Interventions for Psychotic Disorders: A Systematic Review.

Biagianti B, Quraishi SH, Schlosser DA.

Psychiatr Serv. 2018 Apr 1;69(4):377-388. doi: 10.1176/appi.ps.201700283. Epub 2017 Dec 15.

4.

The feasibility, acceptability, and outcomes of PRIME-D: A novel mobile intervention treatment for depression.

Schlosser DA, Campellone TR, Truong B, Anguera JA, Vergani S, Vinogradov S, Arean P.

Depress Anxiety. 2017 Jun;34(6):546-554. doi: 10.1002/da.22624. Epub 2017 Apr 18.

5.

Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.

Loewy R, Fisher M, Schlosser DA, Biagianti B, Stuart B, Mathalon DH, Vinogradov S.

Schizophr Bull. 2016 Jul;42 Suppl 1:S118-26. doi: 10.1093/schbul/sbw009. Epub 2016 Feb 22.

6.

Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.

Schlosser DA, Campellone TR, Biagianti B, Delucchi KL, Gard DE, Fulford D, Stuart BK, Fisher M, Loewy RL, Vinogradov S.

Schizophr Res. 2015 Dec;169(1-3):204-208. doi: 10.1016/j.schres.2015.10.036. Epub 2015 Oct 31.

7.

Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.

Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon TD.

J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):848-58. doi: 10.1016/j.jaac.2014.04.020. Epub 2014 Jun 2.

8.

Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia.

Schlosser DA, Fisher M, Gard D, Fulford D, Loewy RL, Vinogradov S.

Schizophr Res. 2014 Sep;158(1-3):52-7. doi: 10.1016/j.schres.2014.06.024. Epub 2014 Jul 5.

9.

In people with ultra high risk symptoms, risk of transition to psychotic disorders is highest in the first 2 years.

Schlosser DA.

Evid Based Ment Health. 2014 May;17(2):39. doi: 10.1136/eb-2013-101568. Epub 2014 Mar 3. No abstract available.

10.

Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis.

Schlosser DA, Pearson R, Perez VB, Loewy RL.

Adolesc Psychiatry (Hilversum). 2012 Apr;2(2):163-171.

11.

A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods.

Schlosser DA, Miklowitz DJ, O'Brien MP, De Silva SD, Zinberg JL, Cannon TD.

Early Interv Psychiatry. 2012 Aug;6(3):283-91. doi: 10.1111/j.1751-7893.2011.00317.x. Epub 2011 Dec 20.

12.

Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon TD.

Schizophr Bull. 2012 Nov;38(6):1225-33. doi: 10.1093/schbul/sbr098. Epub 2011 Aug 8.

13.

Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis.

Schlosser DA, Zinberg JL, Loewy RL, Casey-Cannon S, O'Brien MP, Bearden CE, Vinogradov S, Cannon TD.

Schizophr Res. 2010 May;118(1-3):69-75. doi: 10.1016/j.schres.2010.01.017. Epub 2010 Feb 19.

14.

Multifamily group treatment for schizophrenia.

Stuart BK, Schlosser DA.

Int J Group Psychother. 2009 Jul;59(3):435-40. doi: 10.1521/ijgp.2009.59.3.435. No abstract available.

15.

Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1.

Thomas MK, Devon ON, Lee JH, Peter A, Schlosser DA, Tenser MS, Habener JF.

J Clin Invest. 2001 Jul;108(2):319-29.

16.

Lymphocyte subpopulations in lymphoid organs of rats after acute resistance exercise.

Mastro AM, Schlosser DA, Grove DS, Lincoski C, Pishak SA, Gordon S, Kraemer WJ.

Med Sci Sports Exerc. 1999 Jan;31(1):74-81.

PMID:
9927013
17.

Steroidogenic factor 1 is the essential transcript of the mouse Ftz-F1 gene.

Luo X, Ikeda Y, Schlosser DA, Parker KL.

Mol Endocrinol. 1995 Sep;9(9):1233-9.

PMID:
7491115

Supplemental Content

Loading ...
Support Center